other material
confidence high
sentiment neutral
materiality 0.45
Silo Pharma raises ~$850K private placement at $1.50/share; net proceeds ~$815,000
Silo Pharma, Inc.
- Sold 136,005 common shares at $1.50 and pre-funded warrants for 430,661 shares at $1.4999, exercisable immediately at $0.0001 until fully exercised.
- Gross proceeds ~$850,000; net proceeds expected ~$815,000 after placement agent fees and offering expenses, earmarked for working capital and general corporate purposes.
- Purchasers capped at 4.99% beneficial ownership, adjustable to 9.99% on 61 days' prior notice to the Company.
- Registration Rights Agreement requires a resale registration statement filing within 30 days and effectiveness within 60 days (90 days if SEC conducts a full review).
- Silo obtained a right-of-first-refusal waiver from H.C. Wainwright for the offering; the placement closed November 6, 2026.